| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -431,0 k € | -152.2% | 825,5 k € | -58.5% | 2,0 M € | +36.0% | 1,5 M € | +15.5% | 1,3 M € | -15.3% | 1,5 M € | +46.3% | 1,0 M € | +42.9% | 715,5 k € | +26.2% | 566,7 k € | -9.9% | 628,8 k € | +23.9% | 507,4 k € | -10.3% | 565,9 k € | |
| EBITDA | -2,5 M € | -41.7% | -1,7 M € | -1022.2% | 189,5 k € | +157.2% | -331,1 k € | -12.1% | -295,4 k € | -778.8% | 43,5 k € | +114.0% | -310,4 k € | -13.2% | -274,2 k € | -40.2% | -195,6 k € | -2015.8% | 10,2 k € | +58.3% | 6,5 k € | +1053.6% | 559,1 € | |
| Operating profit | -3,8 M € | -30.3% | -2,9 M € | -303.6% | -730,5 k € | +38.7% | -1,2 M € | -2.7% | -1,2 M € | -46586.2% | 2,5 k € | +100.6% | -441,7 k € | -61.1% | -274,2 k € | -40.2% | -195,6 k € | -2015.8% | 10,2 k € | +58.3% | 6,5 k € | +1053.6% | 559,1 € | |
| Profit/loss | -3,7 M € | -27.7% | -2,9 M € | -174.2% | -1,1 M € | +12.0% | -1,2 M € | +5.9% | -1,3 M € | -703.2% | -160,9 k € | +69.0% | -519,0 k € | -62.0% | -320,4 k € | -40.0% | -229,0 k € | — | — | — | ||||
| Equity | 19,5 M € | +12.2% | 17,4 M € | +62.9% | 10,7 M € | -10.2% | 11,9 M € | -10.2% | 13,2 M € | +28.4% | 10,3 M € | -1.1% | 10,4 M € | +53.8% | 6,8 M € | +81.9% | 3,7 M € | +7.8% | 3,5 M € | +34.9% | 2,6 M € | +89.3% | 1,4 M € | |
| Total assets | 23,1 M € | +5.3% | 22,0 M € | +6.1% | 20,7 M € | +8.6% | 19,1 M € | +5.5% | 18,1 M € | +10.2% | 16,4 M € | +27.9% | 12,8 M € | +27.9% | 10,0 M € | +52.7% | 6,6 M € | +51.8% | 4,3 M € | +19.1% | 3,6 M € | +112.1% | 1,7 M € | |
| Cash | 622,5 k € | +26.6% | 491,6 k € | +401642.0% | 122,4 € | -99.3% | 18,6 k € | -96.8% | 574,2 k € | -47.7% | 1,1 M € | +210.8% | 353,6 k € | -53.2% | 755,2 k € | +116.5% | 348,7 k € | +178.5% | 125,2 k € | -80.8% | 653,6 k € | +94.7% | 335,7 k € | |
| Debts | 3,6 M € | -21.1% | 4,5 M € | -54.8% | 10,0 M € | +39.0% | 7,2 M € | +49.4% | 4,8 M € | -17.3% | 5,8 M € | +157.4% | 2,3 M € | -26.5% | 3,1 M € | +30.7% | 2,3 M € | +249.1% | 671,5 k € | -11.2% | 755,9 k € | +377.5% | 158,3 k € | |
| Staff | 16,2 | 16,2 | 15,7 | 16,1 | 17,1 | 17,7 | 13,9 | 11,2 | 8,9 | 6,6 | 6 | 5 | ||||||||||||
Public limited company · Mont-Saint-Guibert · incorporated on 31/05/2013 · 16,2 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+26.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Tools4Patient is a Public limited company incorporated in 2013. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Mont-Saint-Guibert. It employs on average 16,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette